A Study of Potential Treatment-Responsive Biomarkers in Hunter Syndrome
Summary
- Eligibility
- for people ages 2-30 (full criteria)
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Paul Harmatz, MD
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Paul Harmatz, MD
Professor, Pediatrics. Authored (or co-authored) 193 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Denali Therapeutics Inc.
- ID
- NCT04007536
- Study Type
- Observational
- Last Updated